← Back to blog
Coivas alternative

TelosRX vs Coivas: GLP-1 Weight Loss Compared

By TelosRX Editorial Team June 21, 2026
Wooden footbridge through a green forest, nature and wellbeing

Comparing TelosRX and Coivas (Idgie Health) for GLP-1 weight loss comes down to price, reach, and accreditation. TelosRX starts at $49/mo, is LegitScript-certified, and ships nationwide; Coivas offers compounded semaglutide with direct provider messaging in select states.

The short answer

For the lowest entry price, a wider medication menu, and nationwide LegitScript-certified access, TelosRX is the easier starting point. Coivas (Idgie Health) is a newer option worth watching, but its geographic reach remains limited and pricing starts higher.

Start your intake →

Quick comparison: TelosRX vs Coivas

Feature TelosRX Coivas (Idgie Health)
Model Online-first, fully asynchronous Online intake + provider consultation (hybrid)
GLP-1 medications Compounded tirzepatide and semaglutide, oral and microdosed options Compounded semaglutide; GLP-1/GIP combo listed
Starting price From $49/mo From $199/mo
Pricing transparency Every plan listed publicly Starting price listed; final cost protocol-dependent
LegitScript-certified Yes Not confirmed
Needle-free options Oral and microdosed tirzepatide Injectable compounded semaglutide
Ongoing support Care-team messaging, dose adjustments, quarterly labs Direct provider messaging; no structured labs listed
Geographic reach Nationwide Select states (expanding)
Provider access Care-team messaging, async Direct individual provider contact

Compounded medications are not FDA-approved. Any prescription is subject to medical approval by a licensed provider, and approval is not guaranteed.

What is TelosRX?

TelosRX is an online-first, LegitScript-certified telehealth pharmacy focused on GLP-1 weight management. It offers compounded tirzepatide and semaglutide, plus needle-free alternatives including oral tirzepatide and microdosed tirzepatide.

The service is fully asynchronous. You complete a short intake online — no appointment to schedule — and a US-licensed provider reviews your information, typically within a few hours. If approved, medication ships free with 48-hour delivery. You can message your care team anytime, and every plan price is listed publicly before you commit.

Browse tirzepatide and semaglutide options, or start your intake to see which plan fits your goals.

What is Coivas (Idgie Health)?

Coivas is the consumer-facing brand of Idgie Health, a telehealth company that offers compounded semaglutide for weight management alongside other wellness services including NAD+ therapy, hormone therapy, and peptides. The company operates a HIPAA-compliant platform with licensed providers and licensed US compounding pharmacy partners.

Coivas takes a more individualized, provider-led approach: patients complete an online intake and then connect directly with their assigned provider for a clinical evaluation before any medication is prescribed. This hands-on model gives patients a direct relationship with a single clinician. Geographic availability is currently limited to select states, with expansion underway.

Medications: what each program offers

Both programs use medications from the GLP-1 drug class. Semaglutide is a GLP-1 receptor agonist studied extensively for weight management. Tirzepatide is a dual GLP-1 and GIP receptor agonist and the active ingredient in FDA-approved Zepbound.

The compounded versions offered by both TelosRX and Coivas are not FDA-approved — they are prepared by licensed US compounding pharmacies under federal compounding regulations and are not the same as, nor generic versions of, branded medications. For context on prescription weight-loss medications, see the NIH NIDDK overview.

TelosRX offers compounded tirzepatide and compounded semaglutide, plus two formats that set it apart: needle-free oral tirzepatide and a microdosed tirzepatide plan designed for those who want a gentler entry dose. Coivas currently centers on compounded semaglutide, with a GLP-1/GIP combination listed on its site. For background on tirzepatide's FDA approval as a weight-loss medication, see the FDA announcement.

Key takeaway: TelosRX starts at $49/mo and offers both tirzepatide and semaglutide in multiple formats — including needle-free options — nationwide. Coivas brings a personal provider relationship and a broader wellness menu, but currently centers on compounded semaglutide and serves select states.

Pricing and transparency

Price is one of the clearest differences between these two programs. TelosRX publishes every plan upfront:

  • From $49 a month — microdosed tirzepatide, 12-month plan
  • $99 your first month — standard tirzepatide, 12-month plan
  • $145, $199, or $399 first month — 6-month, 3-month, or single-month plans

Coivas lists a starting price of $199 per month for compounded semaglutide, with a note that final pricing depends on your individualized protocol. No first-month discount or multi-month plan structure is publicly listed. TelosRX accepts HSA/FSA and charges no membership fee; you can cancel anytime. Start your intake to see your exact TelosRX plan price in minutes.

How the process works

TelosRX is fully asynchronous. You fill out a short intake — roughly five minutes — and a licensed provider reviews it, often within a few hours. No appointment, no waiting room, no video call required. If approved, medication ships free with 48-hour delivery. Any prescription is subject to medical approval by a licensed provider, and approval is not guaranteed.

Coivas takes a hybrid approach. You complete an online intake, then connect directly with a licensed provider for a clinical evaluation before any medication decision is made. The company notes that medication typically ships within 48 hours of that consultation. This added step means Coivas takes a bit longer from intake to delivery, but patients who value speaking with their specific provider directly may appreciate the model.

Coaching and ongoing support

TelosRX includes care-team messaging, dose adjustments as your body responds, and quarterly labs — all built into the program. You are not starting and then left on your own.

Coivas emphasizes direct access to your individual provider via messaging throughout treatment, with protocol adjustments available as needed. Structured lab work and formalized coaching programs are not listed publicly in Coivas's current offering.

The approaches reflect different philosophies: TelosRX covers clinical touchpoints systematically through a care team, while Coivas builds a more personal relationship with one provider. Neither is inherently better — it depends on what you value in an ongoing clinical relationship.

Safety and medical oversight

Both programs gate medication behind licensed provider review. No prescription is issued automatically.

GLP-1 medications are not appropriate for everyone. Providers typically screen for a personal or family history of medullary thyroid cancer, pancreatitis, pregnancy, and other contraindications. Common early side effects include nausea and digestive changes, which often ease as the body adjusts.

TelosRX includes quarterly labs and ongoing care-team access, so any concerns can be flagged promptly. Share your complete medical history during intake, since any approval is subject to medical review by a licensed provider.

Which service is right for you?

Recommended
TelosRX

Best for anyone who wants the lowest entry price, a wide medication menu including needle-free options, nationwide access, and LegitScript-certified clinical oversight with quarterly labs.

Coivas (Idgie Health)

Best for patients who want direct, ongoing access to a single named provider and appreciate a broader wellness platform (NAD+, hormones, peptides) alongside their GLP-1 program — and are in a state where Coivas currently operates.

For most people searching for a cost-effective, flexible, and nationally available GLP-1 program, TelosRX is the more straightforward choice. If a close individual provider relationship is your priority and Coivas is available in your state, it is worth considering.

Start your treatment →

Frequently Asked Questions

Is TelosRX a legitimate telehealth service?

Yes. TelosRX is LegitScript-certified, an independent accreditation standard for online healthcare providers and pharmacies. Medications are compounded by licensed US compounding pharmacies, and every prescription is subject to medical approval by a licensed provider. Approval is not guaranteed.

Are the GLP-1 medications from TelosRX or Coivas FDA-approved?

No. The compounded semaglutide and compounded tirzepatide offered by both TelosRX and Coivas are not FDA-approved. They are prepared under federal compounding regulations by licensed US compounding pharmacies and are not the same as branded medications like Ozempic, Wegovy, or Zepbound.

How does TelosRX pricing compare to Coivas?

TelosRX publishes all plan prices publicly and starts from $49 a month (microdosed tirzepatide, 12-month plan), with standard tirzepatide from $99 your first month. Coivas lists a starting price of $199 a month for compounded semaglutide, with final pricing dependent on your individualized protocol.

Does Coivas require a video or phone consultation?

Based on publicly available information, Coivas uses a hybrid model: patients complete an online intake and then connect directly with a licensed provider for a clinical evaluation before any medication is prescribed. TelosRX is fully asynchronous — no appointment or call is needed. A licensed provider reviews your intake and makes a prescribing decision without a scheduled visit.

Is TelosRX available nationwide?

Yes. TelosRX operates as a nationwide, online-first telehealth pharmacy and ships to patients across the US. Coivas currently serves select states, with availability expanding over time. Check Coivas's state availability page if you are outside the states where it currently operates.

What makes Coivas's approach distinctive compared to TelosRX?

Coivas emphasizes a direct relationship with a single named licensed provider throughout your treatment, which some patients find reassuring. It also offers a broader wellness platform beyond GLP-1s, including NAD+ therapy, hormone therapy, and peptides. TelosRX is more specialized, focusing specifically on GLP-1 weight management with a wider medication menu and LegitScript certification.

TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.

Start your private evaluation at TelosRX.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX